Inside US FDA’s Return To In-Person Meetings

 
• By Derrick Gingery
  
hybrid meeting
The FDA will only allow "core participants" with speaking roles to attend hybrid meetings in person. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers